Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
- 25 January 2006
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 151 (2), 257-264
- https://doi.org/10.1016/j.ahj.2005.04.020
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failureAmerican Heart Journal, 2004
- Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: a double-blind, randomized, placebo-controlled studyAmerican Heart Journal, 2004
- Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trialAmerican Heart Journal, 2004
- A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapyAmerican Heart Journal, 2004
- Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular functionThe American Journal of Cardiology, 2004
- Comparison of early and late results of a Carbofilm-coated stent versus a pure high-grade stainless steel stent (the Carbostent-Trial)The American Journal of Cardiology, 2004
- Effect of a cardiac rehabilitation program on left ventricular diastolic function and its relationship to exercise capacity in patients with coronary heart disease: Experience from a randomized, controlled studyAmerican Heart Journal, 2004
- Primary stenting of occluded native coronary arteries: Final results of the Primary Stenting of Occluded Native Coronary Arteries (PRISON) studyAmerican Heart Journal, 2004
- Randomized comparison of balloon angioplasty versus silicon Carbon-Coated stent implantation for de novo lesions in small coronary arteriesThe American Journal of Cardiology, 2004
- Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritisThe American Journal of Cardiology, 2002